Skip to main content

A Randomized Phase II Study Evaluating Pembrolizumab vs Topotecan in the Second-line Treatment of Patients with Small Cell Lung Cancer

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Alliance Foundation Trials, LLC

Start Date

July 25, 2017

End Date

May 31, 2018
 

Administered By

Duke Cancer Institute

Awarded By

Alliance Foundation Trials, LLC

Start Date

July 25, 2017

End Date

May 31, 2018